Press Releases | Microbix Biosystems Inc.
50646
page-template,page-template-blog-standard,page-template-blog-standard-php,page,page-id-50646,page-child,parent-pageid-1298,edgt-core-1.0,,vigor-ver-1.10, vertical_menu_with_scroll,side_menu_slide_with_content,width_370,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

Press Releases

Microbix Reports Significant Revenue Growth in First Quarter

Company Records Non-Cash Debt Restructuring Expense to Refinance Debentures and Fund Continued Growth Initiatives TORONTO, February 14, 2017 - Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December...

Read More

Microbix Appoints Meridian Life Science as Distributor in Asia Pacific – Meridian an Exclusive Distributor in China, Hong Kong, Taiwan and Macau

TORONTO, January 12, 2017 - Microbix Biosystems Inc. (TSX: MBX) (“Microbix”), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the “Agreement”) with Meridian Life Science, Inc. (“Meridian”) a wholly owned company of Meridian Bioscience, Inc. (NASDAQ: VIVO) a...

Read More

MICROBIX ARRANGES NEW REVOLVING CREDIT FACILITY – Concurrently Renegotiates Terms of Convertible Debentures

TORONTO, December 12, 2016 - Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), an innovator of biological products and technologies, today announced that it has arranged a new secured revolving credit facility jointly with The Toronto-Dominion Bank (“TD Bank”) and Export Development Canada (“EDC”). The...

Read More

Microbix Appoints New Chief Financial Officer

TORONTO November 1, 2016 — Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced that Charles Wallace, the Company’s Chief Financial Officer, is retiring on December 31, 2016 after serving in this capacity since September 2013. Microbix also announced that...

Read More